Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
All APAC Global
All APAC Global
All APAC Global
All APAC Global
Lower Cholesterol Treatment Breakthrough 2018-08-30 11:44
WuXi Biologics Selected into the Hang Seng HK 35 Index 2018-08-30 10:08
Concord Medical Reports Financial Results for the First Half of 2018 2018-08-29 18:00
Luye Pharma Releases its Financial Results for the First Half of 2018: Double-Digit Growth in Core Product Sales, Exceeded Expectations in Sales, R&D and M&As 2018-08-29 17:40
KinoPharma and National Institutes for Quantum and Radiological Science and Technology Launch Collaborative Research Project for Exploring New Drug Development for Alzheimer's Disease 2018-08-29 14:00
China Biologic Responds to Lawsuit Filed in Cayman Islands by Former Chairman 2018-08-29 05:00
CStone's Anti-CTLA-4 Antibody CS1002 Receives IND Approval in China 2018-08-28 10:16
China YCT International Group to Hold its Annual Meeting of Stockholders on October 8, 2018 Beijing Time 2018-08-28 04:47
China Biologic Announces Updates on Unsolicited Acquisition Proposals and Strategic Private Placement 2018-08-24 20:00
Bridge Biotherapeutics Presented Preclinical Study Results on BBT-877, an Autotaxin inhibitor at the IPF Summit 2018 2018-08-23 06:00
iHuman Team at ShanghaiTech University Deciphers the First Human Frizzled Receptor Structure 2018-08-23 01:00
WuXi AppTec Appoints Edward Hu as Co-CEO 2018-08-22 18:35
China Biologic Announces Receipt of Competing Non-Binding Acquisition Proposal 2018-08-21 20:00
Shineco, Inc. Enters into Strategic Cooperation Agreement with the People's Government of Bayingolin Mongol Autonomous Prefecture for Apocynum Industrial Integration Construction Project 2018-08-20 21:30
SEC Concludes Investigation of Sinovac 2018-08-20 19:00
Shanghai ChemPartner Announces Merger Deal Closure with Quantum 2018-08-17 00:42
Adlai Nortye Eyes Global Expansion With the Opening of Its First International Site in USA 2018-08-16 22:00
China Pharma Holdings, Inc. Reports Second Quarter 2018 Financial Results 2018-08-15 18:22
China Biologic Names Bing Li as New CEO 2018-08-13 20:00
BeiGene Initiates New Phase 3 Trial of Anti-PD-1 Antibody Tislelizumab Combined with Chemotherapy as First-line Treatment for Patients with Advanced Squamous Non-Small Cell Lung Cancer in China 2018-08-09 17:05
1 233 234 235 236 237 430